These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14621973

  • 1. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
    Ozeki T, Katsuyama H, Yasuzawa Y, Takashima Y, Kasai T, Eguchi T, Kakiuchi H, Yuasa H, Okada H.
    AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
    [Abstract] [Full Text] [Related]

  • 2. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. II: effects of curing on the medicine release from AYC-coated tablets.
    Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N.
    Int J Pharm; 2000 Nov 19; 209(1-2):69-77. PubMed ID: 11084247
    [Abstract] [Full Text] [Related]

  • 3. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive I. AYC as a novel coating material.
    Kasai T, Eguchi T, Ishiwaki N, Kaneshige J, Ozeki T, Yuasa H.
    Int J Pharm; 2000 Aug 25; 204(1-2):53-9. PubMed ID: 11011986
    [Abstract] [Full Text] [Related]

  • 4. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
    Mitra B, Wolfe C, Wu SJ.
    Drug Dev Ind Pharm; 2018 May 25; 44(5):817-828. PubMed ID: 29300107
    [Abstract] [Full Text] [Related]

  • 5. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. III. AYC aqueous coating onto granules and film formation mechanism of AYC.
    Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N.
    Int J Pharm; 2002 Apr 26; 237(1-2):15-22. PubMed ID: 11955800
    [Abstract] [Full Text] [Related]

  • 6. Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.
    Veronica N, Lee ESM, Heng PWS, Liew CV.
    Int J Pharm; 2024 Aug 15; 661():124467. PubMed ID: 39004293
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
    Vercruysse J, Córdoba Díaz D, Peeters E, Fonteyne M, Delaet U, Van Assche I, De Beer T, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2012 Sep 15; 82(1):205-11. PubMed ID: 22687571
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
    Wang C, Huang H, Jia M, Jin S, Zhao W, Cha R.
    Carbohydr Polym; 2015 Oct 05; 130():275-9. PubMed ID: 26076627
    [Abstract] [Full Text] [Related]

  • 11. Extrusion granulation and high shear granulation of different grades of lactose and highly dosed drugs: a comparative study.
    Keleb EI, Vermeire A, Vervaet C, Remon JP.
    Drug Dev Ind Pharm; 2004 Jul 05; 30(6):679-91. PubMed ID: 15285342
    [Abstract] [Full Text] [Related]

  • 12. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
    Khan A.
    PLoS One; 2021 Jul 05; 16(12):e0261051. PubMed ID: 34882723
    [Abstract] [Full Text] [Related]

  • 13. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J, Laungtana-Anan M, Sriamornsak P, Limmatvapirat S, Puttipipatkhachorn S, Lim LY, Khor E.
    J Control Release; 2004 Sep 14; 99(1):15-26. PubMed ID: 15342177
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a drug with wax-like properties as a melt binder.
    Dhumal RS, Shimpi SL, Chauhan B, Mahadik KR, Paradkar A.
    Acta Pharm; 2006 Dec 14; 56(4):451-61. PubMed ID: 19839137
    [Abstract] [Full Text] [Related]

  • 15. Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy.
    Otsuka M, Mouri Y, Matsuda Y.
    AAPS PharmSciTech; 2003 Dec 14; 4(3):E47. PubMed ID: 14621979
    [Abstract] [Full Text] [Related]

  • 16. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R, Thommes M, Rasenack N, Krumme M, Moll KP, Kleinebudde P.
    Int J Pharm; 2015 Dec 30; 496(1):12-23. PubMed ID: 26024821
    [Abstract] [Full Text] [Related]

  • 17. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ohike A, Ibuki R, Higaki K, Kimura T.
    J Control Release; 2005 Nov 28; 108(2-3):386-95. PubMed ID: 16253377
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P, Martelli S, Wehrlé P.
    Drug Dev Ind Pharm; 2005 Jan 28; 31(1):109-21. PubMed ID: 15704862
    [Abstract] [Full Text] [Related]

  • 19. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM, Ibne-Wahed MI, Khondkar P, Ahmed M, Islam R, Barman RK, Islam MA.
    Pak J Pharm Sci; 2008 Oct 28; 21(4):455-9. PubMed ID: 18930870
    [Abstract] [Full Text] [Related]

  • 20. Fast-melting tablets based on highly plastic granules.
    Fu Y, Jeong SH, Park K.
    J Control Release; 2005 Dec 05; 109(1-3):203-10. PubMed ID: 16260059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.